Synopsys, Inc. (NASDAQ:SNPS) Q4 2024 Earnings Call Transcript

Full Article
Synopsys, Inc. (NASDAQ:SNPS) Q4 2024 Earnings Call Transcript

Synopsys delivered impressive results in Q4 2024, surpassing revenue expectations and achieving a record $6 billion in annual revenue. The company experienced a 15% year-over-year growth, driven by advancements in AI and design automation technologies. The CEO highlighted the strategic importance of AI in transforming technology R&D and the company's commitment to supporting industries in their AI initiatives.

The planned acquisition of Ansys is set to enhance Synopsys' capabilities in AI-powered design solutions, merging electronics with physics for better product insights. The company is also witnessing a significant shift towards Multi-Die designs, which are expected to dominate the semiconductor landscape by 2027. With a strong focus on execution and innovation, Synopsys aims to maintain its growth trajectory into 2025.

• Synopsys achieved record revenue driven by AI and design automation advancements.

• The acquisition of Ansys will enhance AI-powered design capabilities.

Key AI Terms Mentioned in this Article

AI Optimization Engines

AI optimization engines are integrated into Synopsys products to enhance design efficiency and performance.

Generative AI

Generative AI is being incorporated into Synopsys' platform to improve design workflows and outcomes.

Multi-Die Designs

Multi-Die designs represent a new frontier in chip architecture, increasing complexity and integration needs.

Companies Mentioned in this Article

Synopsys

Synopsys specializes in electronic design automation and is leveraging AI to drive innovation in chip design.

Ansys

Ansys provides engineering simulation software, and its acquisition will enhance Synopsys' AI-driven design solutions.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics